Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)
Stock Information for Aditxt Inc.
Loading
Please wait while we load your information from QuoteMedia.